v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 59,968 $ 91,187
Restricted cash 154,657 114,829
Loans receivable at fair value 2,778,523 2,962,352
Capitalized software and other intangibles, net 86,588 114,735
Right of use assets - operating 9,775 21,105
Other assets 137,592 107,680
Total assets 3,227,103 3,411,888
Liabilities    
Secured financing 535,469 289,951
Asset-backed notes at fair value 1,080,690 1,780,005
Asset-backed borrowings at amortized cost 984,333 581,468
Acquisition and corporate financing 203,751 258,746
Lease liabilities 18,200 28,376
Other liabilities 50,851 68,938
Total liabilities 2,873,294 3,007,484
Note 15 Leases, Commitments and Contingencies
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at December 31, 2024 and December 31, 2023; 36,383,879 shares issued and 36,111,856 shares outstanding at December 31, 2024; 34,741,076 shares issued and 34,469,053 shares outstanding at December 31, 2023 7 7
Common stock, additional paid-in capital 612,642 584,555
Accumulated deficit (252,531) (173,849)
Treasury stock at cost, 272,023 and 272,023 shares at December 31, 2024 and December 31, 2023 (6,309) (6,309)
Total stockholders’ equity 353,809 404,404
Total liabilities and stockholders' equity $ 3,227,103 $ 3,411,888

Source

HTML PDF
XBRL
ZIP